“We finally beat Medicare,” President Joe Biden claimed during his calamitous June 27 debate with former President Donald Trump.
The White House later clarified: “He meant to say that he beat big pharma.”
But seniors’ wallets are taking the beating.
Changes made to Medicare’s prescription drug coverage by the Biden-Harris administration and congressional Democrats—with not a single Republican vote—as part of the so-called Inflation Reduction Act are sending premiums sky-high, eliminating plans for at least 3 million seniors, and making it harder to access medications.
The data shows that under four years of Biden-Harris administration policies (plan years 2022 through 2025), the national average monthly premium paid by Medicare beneficiaries for stand-alone Part D prescription drug plans has increased by 57%.
At the same time, the average number…
